This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Arthur J. Gallagher Set to Report Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Better performances in both segments are likely to aid AJG's fourth-quarter results.
Will High Operating Costs Ail Marsh & McLennan in Q4 Earnings?
by Zacks Equity Research
MMC's Q4 results are likely to be aided by strength in the Risk and Insurance Services and Consulting segments, partly offset by elevated compensation and benefits expenses.
Should iShares Russell Mid-Cap Value ETF (IWS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWS
Should iShares Morningstar Mid-Cap Growth ETF (IMCG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IMCG
Arthur J. Gallagher (AJG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Arthur J. Gallagher (AJG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
L.A. Wildfires: 3 Insurance Stocks Standing Strong Amid Recovery
by Kaibalya Pravo Dey
Insurers can become a guiding force for recovery, which is important because a rising tide will often lift all boats in an industry.
Should Vanguard Mid-Cap Value ETF (VOE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOE
Compelling Reasons to Hold on to Arthur J. Gallagher Stock for Now
by Zacks Equity Research
AJG gains on the back of strategic acquisitions, solid retention and improving renewal premiums, as well as financial flexibility
Should You Buy, Sell or Hold Marsh & McLennan Stock at a 7.47X P/B?
by Zacks Equity Research
MMC is currently aided by strong segmental contribution, margin expansion and inorganic growth initiatives.
Zacks Industry Outlook Brown and Brown, Marsh & McLennan, Arthur J. Gallagher & Co and Willis Towers Watson
by Zacks Equity Research
Brown and Brown, Marsh & McLennan, Arthur J. Gallagher & Co and Willis Towers Watson have been highlighted in this Industry Outlook article.
4 Stocks to Watch From the Prospering Insurance Brokerage Industry
by Sushmita Sarker
Higher demand for insurance products, strategic acquisitions and the adoption of technology should drive the performance of Zacks Insurance Brokerage industry players like BRO, MMC, AJG and WTW.
Arthur J. Gallagher Sustains Its Acquisition Spree, Bolsters Portfolio
by Zacks Equity Research
The acquisitions of Schuetz, DMc Insurance, AssuredPartners and others are set to boost AJG's growth, retail brokerage operations and expand the geographical footprint.
AJG Rallies 35% YTD but Lags Industry: How to Play the Stock
by Zacks Equity Research
Arthur J. Gallagher gains on the back of solid performance of its Brokerage and Risk Management segments, strategic buyouts and effective capital deployment.
Should iShares Russell Mid-Cap ETF (IWR) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWR
Why Is Brown & Brown (BRO) Up 8% Since Last Earnings Report?
by Zacks Equity Research
Brown & Brown (BRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Vanguard Mid-Cap Value ETF (VOE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOE
eHealth Incurs Q3 Loss on Lower Commissions, Shares Down 6.1%
by Zacks Equity Research
EHTH's third-quarter results suffer from lower commissions and other revenues. Lower expenses partially offset the negatives.
Regional Management Shares Plunge 9.3% Despite Q3 Earnings Beat
by Zacks Equity Research
RM's third-quarter earnings benefit from rising interest and fee income and improved efficiency ratio. The hurricane impact, coupled with declining net insurance income, partially offset the results.
Encore Capital Q3 Earnings Miss Estimates on Lower Purchases by Cabot
by Zacks Equity Research
ECPG's third-quarter earnings suffer from rising operating expenses and the competitive environment in the U.K. Improved portfolio purchasing in the United States partially offset the negatives.
ProAssurance Q3 Earnings Beat on Strong Net Investment Income
by Zacks Equity Research
PRA's third-quarter earnings benefit from improving underwriting results in its Specialty P&C segment. Declining profits in the Segregated Portfolio Cell Reinsurance unit partially offset the positives.
Top Analyst Reports for Oracle, Micron Technology & Medtronic
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), Micron Technology, Inc. (MU) and Medtronic plc (MDT), as well as a micro-cap stock The Cato Corporation (CATO).
PRA Group's Shares Up 17.8% Since Q3 Earnings Beat Estimates
by Zacks Equity Research
PRAA's third-quarter results benefit from strong cash collection and portfolio income growth. Higher expenses partially offset the positives.
MarketAxess Q3 Earnings Beat on Strong Credit Trading Volumes
by Zacks Equity Research
MKTX's third-quarter results benefit from higher commissions, driven by improved trading volumes. Higher expenses partially offset the results.
Erie Indemnity Q3 Earnings Top on Higher Management Fee Revenues
by Zacks Equity Research
ERIE's Q3 results reflect higher management fees and increased net investment income, offset by higher expenses.
WTW Q3 Earnings Top on Higher Revenues, Transformation Program
by Zacks Equity Research
Willis Tower's third-quarter results reflect benefits from strong revenue contributions from the Health, Wealth & Career and Risk & Broking segments,